Not recommended or commissioned*. This may include drugs, treatments or medical devices.
For patients that are already on the medicine/treatment/medical device prior to the DNP classification, this should not be withdrawn abruptly from patients, but should be continued until the next clinical review where their NHS clinician will decide whether it is appropriate to switch or stop treatment or submit an individual funding request if in exceptional circumstances on-going prescribing is considered clinically appropriate.
*Clinicians should submit an individual funding request, and await a positive outcome, before initiation of treatment for a DNP medicine/treatment/medical device for NHS prescribing.
JAPC does not recommend for use except in exceptional circumstances.
Considered suitable for a consultant or specialist, usually within a secondary or tertiary care services, to initiate and continue prescribing.
Initiated in secondary care or other specialist setting but are suitable for GPs to continue on-going prescribing under a shared care protocol, once the patient has been stabilised or dose predictable.
Regarded as suitable for primary care prescribing.
You can also view a complete listing of all drugs.